| Financial Year |
March 31 2023 |
| Monetary Funds |
3,868,217,128.42 |
| Held-for-trading Financial Assets |
5,810,021,336.67 |
| Notes Receivable |
1,567,705,951.03 |
| Accounts Receivable |
8,158,834,200.21 |
| Advances to Suppliers |
1,220,606,462.57 |
| Other Receivables |
378,916,934.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,435,035.21 |
| Dividend Receivable |
-- |
| Inventories |
8,188,202,299.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
138,287,594.08 |
| Other Current Assets |
2,434,019,517.50 |
| Total Current Assets |
34,389,182,406.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
185,489,634.08 |
| Long-term Equity Investment |
283,580,960.32 |
| Investment Properties |
334,107,438.14 |
| Fixed Assetes |
4,468,189,263.00 |
| Under-construction Projects |
849,358,127.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
988,993,876.83 |
| R&D expenses |
398,323,887.70 |
| Goodwill |
131,905,143.18 |
| Long-Term Deferred and Prepaid Expenses |
174,614,887.62 |
| Deferred Income Tax Assets |
470,570,479.58 |
| Other Non-Current Assets |
235,706,745.08 |
| Sub-Total of Non-Current Assets |
11,838,080,356.67 |
| Total Assets |
46,227,262,763.40 |
| Short-Term Loans |
730,095,096.80 |
| Trading Financial liabilities |
37,503,427.70 |
| Notes Payable |
3,607,080,946.26 |
| Accounts Payable |
5,892,962,425.78 |
| Accounts Received In Advance |
1,812,411.13 |
| Employee Compensation Payable |
701,688,285.72 |
| Taxes Payable |
533,771,202.65 |
| Interest Payable |
-- |
| Dividend Payable |
36,686,114.80 |
| Other payables |
843,919,494.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,503,274,850.40 |
| Other Current Liabilities |
537,779,286.60 |
| Sub-Total of Current Liabilities |
18,305,422,031.80 |
| Long-term Loans |
6,013,053,717.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,830,302.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
345,671,111.30 |
| Deferred Income Tax Liabilities |
340,042,901.13 |
| Other Non-Current Liabilities |
16,153,856.29 |
| Sub-Total of Non-Current Liabilities |
8,355,811,752.50 |
| Total Liabilities |
26,661,233,784.30 |
| Paid-In Capital(Or Share Stock) |
1,782,245,970.00 |
| Capital Surplus |
5,364,428,264.36 |
| Surplus Reserve |
1,023,519,511.31 |
| LESS:Treasury Stock |
118,197,845.20 |
| Undistributed Profits |
10,335,318,071.68 |
| Minority Stockholder's Interest |
914,399,975.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,651,629,003.91 |
| Owner's Equity（Stockholder's Equity） |
19,566,028,979.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,227,262,763.40 |
